Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Benner

Thoracic Surgery (Cardiothoracic Vascular Surgery) North Charleston, SC Medical Doctor

NPI 1447336177 CMS profile 292130

9313 Medical Plaza Dr, Suite 304, North Charleston, SC 29406

Open in the dashboard

General payments

$11,094

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Benner of North Charleston, SC is reported in the CMS Open Payments database as having received $11,094 across 178 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $960 33
2024 General $592 15
2023 General $1,548 21
2022 General $1,544 27
2021 General $2,261 33
2020 General $3,373 26
2019 General $817 23

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Benner
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to James Benner were reported at $960. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year James Benner Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $817 $886 $178–$3,167 $163
2020 $3,373 $341 $108–$1,605 $114
2021 $2,261 $453 $125–$1,886 $132
2022 $1,544 $695 $180–$2,566 $149
2023 $1,548 $745 $205–$2,662 $160
2024 $592 $799 $214–$2,967 $164
2025 $960 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $3,388 24 payments
  2. Atricure, Inc. $1,886 41 payments
  3. W. L. Gore & Associates, Inc. $1,790 13 payments
  4. Silk Road Medical, Inc. $1,097 8 payments
  5. Philips Electronics North America Corporation $388 8 payments
  6. Boston Scientific Corporation $349 14 payments
  7. Edwards Lifesciences Corporation $306 17 payments
  8. CVRx, Inc. $275 3 payments
  9. Medtronic, Inc. $272 9 payments
  10. LivaNova USA, Inc. $190 2 payments
  11. Other $1,155 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $9,550 172 payments
  2. Travel and Lodging $1,040 5 payments
  3. Education $505 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $3,049 25 payments
  2. CT THROMBECTOMY SYSTEM KIT $1,242 11 payments
  3. ClotTriever $1,242 6 payments
  4. FlowTriever $1,242 6 payments
  5. ENROUTE 0.014 Guidewire $932 6 payments
  6. ENROUTE Transcarotid Stent System $932 6 payments
  7. ENROUTE Transcarotid Neuroprotection System $932 6 payments
  8. ENHANCE Transcarotid Peripheral Access Kit $932 6 payments
  9. GORE VIABAHN VBX Balloon Expandable Endo $870 8 payments
  10. VIABAHN VBX Balloon Expandable Endoprosthesis $654 2 payments
  11. Other $6,583 154 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

64

Median for Thoracic Surgery: 42

Drug cost

$684

Median for Thoracic Surgery: $318

Branded share of claims

70.3%

Median for Thoracic Surgery: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $286
Clopidogrel Clopidogrel Bisulfate Brand 22 $220
Oxycodone Hcl Generic 19 $178

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 910 Part D prescribers listed as Thoracic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 111 billing codes

Paid by Medicare

$200,298

Medicare's payments for the services billed

Medicare patients

189

Average age 75

Services billed

488

74 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 73%
Heart failure 60%
Diabetes 51%
Atrial fibrillation 48%
Arthritis 48%
Chronic kidney disease 47%
COPD 46%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record